About: Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2004 (uk) im August 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2004 (ast) scientific article published on 01 August 2004 (en)
publication date	wds:Q60321491-75375F56-1869-4561-B61A-B3A02416DC9A
publication date	2004-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60321491-E6A0B7E0-70B7-42B9-B093-CF46B61B61AD
language of work or name	English
author name string	wds:Q60321491-0079D947-419B-4022-B663-7D8988FA7042 wds:Q60321491-16C8D75D-C42A-4481-B133-DC64E9E72ABA wds:Q60321491-78AE6A7C-2708-4661-A638-533CB0B5424C wds:Q60321491-7E38B71E-49FE-4A39-88C7-2C5D42907D8A wds:Q60321491-8040C1CE-6494-415F-BB55-C9D0843A0C57 wds:Q60321491-91654F57-5DD4-49C9-AAEA-A98BB626C9C7
author name string	Gert Jan Fleuren Sjoerd H van der Burg Rienk Offringa Jan Wouter Drijfhout Jeanette M van der Hulst Mariëtte I E van Poelgeest
rdfs:label	Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (en) Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (nl)
skos:prefLabel	Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (en) Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (nl)
name	Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (en) Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6 (nl)
author	wds:Q60321491-3CB7AF55-0C5D-417B-A37E-68931D8D5CF0 wds:Q60321491-55905665-879A-4D09-A3CB-CFC19E46DD63 wds:Q60321491-A16AFE44-3A91-4F29-BEEA-DAA2D4B53059
author	Cornelis J. M. Melief Annemieke De Jong Gemma Kenter
title	wds:Q60321491-D71D62AF-88BA-4895-8516-107C19D42FC4
title	Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6 (en)
page(s)	wds:Q60321491-071AE407-EF21-405D-8C11-43FFF982942B
page(s)	5449-5455
instance of	wds:Q60321491-BFEE793A-D429-44EC-84BE-DA457C06D946
instance of	scholarly article
main subject	wds:Q60321491-6DF229F9-2610-41E5-889B-0CB9AF49CE98
main subject	cervix uterine cancer
PubMed ID	wds:Q60321491-2F885A54-28BB-44FA-953C-AA3BB8FF7A68
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15289354
PubMed ID	15289354
published in	wds:Q60321491-977C96D3-1E1A-412F-B57E-9C10AB74D2CA
published in	Cancer Research
issue	wds:Q60321491-0ABA091D-7F9D-4FBD-BC63-9775E52B4188
volume	wds:Q60321491-054CB44B-CCF9-4F1B-981B-1B346D722A49
issue	15
volume	64
DOI	wds:Q60321491-D9E4145B-A16C-4FEB-AA7C-CB54FDFD384F
DOI	http://dx.doi.org/10.1158/0008-5472.CAN-04-0831
DOI	10.1158/0008-5472.CAN-04-0831
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60321491
is cites work of	The biology and life-cycle of human papillomaviruses. Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. The immune response to papillomavirus during infection persistence and regression Human papillomavirus molecular biology and disease association Therapy of human papillomavirus-related disease Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention Chapter 5: Updating the natural history of HPV and anogenital cancer Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia Overcoming Barriers to Cervical Cancer Screening Among Asian American Women HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model Correlating immunity with protection for HPV infection Potential functional role of plasmacytoid dendritic cells in cancer immunity Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Alterations of T-cell surface markers in older women with persistent human papillomavirus infection T cell susceptibility to HIV influences outcome of opportunistic infections Immune therapy for human papillomaviruses-related cancers Human papillomavirus and cervical cancer DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls Clinician's guide to human papillomavirus immunology: knowns and unknowns Immunobiology of HPV and HPV vaccines Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix Immunosuppressive tumor microenvironment in cervical cancer patients Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection Evolutionary and biophysical relationships among the papillomavirus E2 proteins

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software